Fundraising Fox

Gregory Harriman

Investor

Partner at BioAdvance

Pennsylvania

Writes $1.5M – $5M checks Β· typically $3.3M

About

Physician-scientist and biomedical executive with 25+ years in academic medicine and the biopharma industry, having led drug and biologics development. Founded Main Line Ventures and sits on several BioAdvance portfolio boards.

Invests in

Biotech

Experience

  1. Optimeos Life SciencesChief Medical Officercurrent2022 β€” presentUnited States
  2. BioAdvance CapitalPartner, Chief Investment Officercurrent2021 β€” presentRadnor, Pennsylvania, United States
  3. Main Line VenturesPresidentcurrent2006 β€” present
  4. Senzo HealthDirectorcurrent2022 β€” present
  5. Opsidio, LLCDirectorcurrent2017 β€” present
  6. TreventisDirectorcurrent2012 β€” present
  7. BioAdvanceVenture Partner2012 β€” 2021Radnor, PA
  8. RIBONOVA INC.Director2016 β€” 2021
  9. Genome Profiling, LLCDirector2017 β€” 2018
  10. Robin Hood VenturesMember2010 β€” 2017
  11. ImmunomeDirector2012 β€” 2017
  12. Enzium, Inc.Director2015 β€” 2017
  13. QR PharmaDirector2012 β€” 2014
  14. Drexel UniversityResearch Professor, School of Biomedical Engineering, Science and Health Systems2010 β€” 2014
  15. Novira TherapeuticsDirector2011 β€” 2012Radnor, PA
  16. Johnson & JohnsonVice President2001 β€” 2009
  17. CentocorExecutive Director1998 β€” 2001
  18. IVAXMedical Director1996 β€” 1998
  19. Baylor College of MedicineAssistant Professor of Medicine1991 β€” 1996Houston, Texas

Education

  1. UC San DiegoM.D., Medicine1977 β€” 1981
  2. University of California, Berkeley1974 β€” 1977

Skills & more

Angel Investing3Business Development9Lifesciences21Biotechnology29Commercialization14Venture Capital16Medical Devices13Clinical Development9Technology Transfer7Healthcare4Start-ups23Immunology7
+12 moreOncologyEntrepreneurshipDrug DevelopmentHardware DiagnosticsDrug DiscoveryScienceClinical TrialsInfectious DiseasesStrategic PlanningPharmaceutical IndustryBiomedical EngineeringBiopharmaceuticals

From Gregory's professional profile.

Same school

Shared employers

Investments

Board seats

AnnovisGenProImmunomeNoviraOpsidioRibonovaTreventis

Per the firm's website.

Colleagues at BioAdvance